跳至主要内容
临床试验/NCT04084392
NCT04084392已完成不适用

Evaluating the Impact of the Bridge Clinic in Patients With Opioid Use Disorder

Vanderbilt University Medical Center2 个研究点 分布在 1 个国家目标入组 335 人开始时间: 2019年11月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
335
试验地点
2
主要终点
Hospital Length of Stay

研究概览

简要总结

This study aims to determine whether referral to the Bridge Clinic reduces overall index hospital length of stay when compared to direct referral to a long-term outpatient addiction provider for patients with active opioid use disorder (OUD) being considered for medications-for-addiction treatment (MAT).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inpatients at VUH with active OUD being considered for MAT.
  • Patient accepting a transitional prescription for buprenorphine-naloxone or IM naltrexone whose outpatient plans are not fixed

排除标准

  • Deemed ineligible for referral to outpatient Bridge Clinic by the Addiction Consult Team (examples include but are not limited to patients with severe, active co-occurring psychiatric disorders requiring a higher level of psychiatric care or patients for whom methadone maintenance is deemed the best choice of MAT).
  • Patients previously randomized in this study.

结局指标

主要结局

Hospital Length of Stay

时间窗: approximately 3 to 42 days

Overall index hospital length of stay measured in days

次要结局

  • Number of MAT Prescriptions Filled by Participant(16 weeks post-randomization)
  • Number of Participants With Successful Care Linkage(16 weeks post-randomization)
  • Hospital and ED Free Days(16 weeks post-randomization)
  • Readmissions and Emergency Department (ED) Visits(16 weeks post-randomization)
  • Overdose(16 weeks post-randomization)
  • Opioid Use Within 30 Days(30 days)
  • Quality of Life - Schwartz Outcome Scale-10 (SOS10).(16 weeks post-randomization)
  • Combined Cost of Index Admission and Subsequent Admissions During the Study Period(16 weeks post-randomization)
  • Mortality(16 weeks post-randomization)
  • Recurrent Opioid Use(16 weeks post-randomization)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David Marcovitz

Assistant Professor of Psychiatry, MD

Vanderbilt University Medical Center

研究点 (2)

Loading locations...

相似试验

Evaluating the Impact of the Bridge Clinic in... | 临床试验